|
(P1879) |
Event-free survival in rheumatic outpatients is rather determined by echocardiographic and neurohormonal signs of HFpEF than underlying disease entity or inflammation |
|
|
M. Breunig, M. Raub, S. Kleinert, C. Morbach, S. Lehmann, H.-P. Tony, S. Frantz, C. E. Angermann, S. Störk (Würzburg) |
|
(P1880) |
Analysis of novel cardiac biomarkers sST2 and IL-33 in chronic heart failure with reduced ejection fraction |
|
|
P. Jirak, M. Lichtenauer, B. Wernly, V. Paar, C. Jung, A. Yilmaz, H. Reinecke, U. C. Hoppe, C. Schulze, D. Kretzschmar, R. Pistulli (Salzburg, AT; Düsseldorf, Schmalkalden, Münster, Jena) |
|
(P1881) |
Cardiac state of the art biomarkers: Do they reflect cardiac magnetic resonance imaging assessed late gadolinium enhancement? |
|
|
M. Natale, M. Harbrücker, T. Papavassiliu, S. Lang, U. Ansari, U. Hoffmann, M. Borggrefe, T. Bertsch, I. Akin, M. Behnes (Mannheim, Nürnberg) |
|
(P1882) |
The MR-proANP paradox: lack of MR-proANP compared to NT-proBNP and high-sensitivity troponins for discrimination of cardiac magnetic resonance imaging assessed left atrial function |
|
|
M. Natale, M. Harbrücker, S. Lindner, D. Ellguth, S. Lang, T. Papavassiliu, U. Ansari, M. Borggrefe, U. Hoffmann, T. Bertsch, I. Akin, M. Behnes (Mannheim, Nürnberg) |
|
(P1883) |
Evaluation of a multimarker panel in chronic heart failure – a 10 years follow-up |
|
|
S. Bauer, C. G. Jungbauer, C. Strack (Regensburg) |
|
(P1884) |
Significant correlation of biomarker NT-proBNP and magnetic resonance imaging T2- and extracellular volume mapping values in patients with symptomatic heart failure |
|
|
A. Koch, A. Magedanz, M. J. M. Schmidt, T. Voigtländer (Frankfurt am Main) |
|
(P1885) |
Use of NT-proBNP to improve the classification of symptoms in outpatients with HFrEF |
|
|
G. Simonis, L. Karolyi, R. Dörr, S. G. Spitzer (Dresden) |
|
(P1886) |
Can mathematical arterialised venous blood gas values using the v-TAC method replace arterial blood gas in patients with respiratory compromise? |
|
|
H. Rittger, A.-C. Klein (Fürth) |